124 results
Page 5 of 7
8-K
EX-1.1
mre6n
13 Apr 17
Catalyst Biosciences Announces Pricing of $18 Million Underwritten Public Offering
12:00am
424B4
ugva5qqhdmsegu7gs
10 Apr 17
Prospectus supplement with pricing info
12:00am
425
EX-2.1
6u1kz93 wiu2as100
6 Mar 15
Business combination disclosure
12:00am
8-K
EX-2.1
0gw3c7vnpxo40dqljv6
6 Mar 15
Targacept and Catalyst Biosciences Enter Definitive Merger Agreement Creating a Protease-Based Hemostasis and Anti-Complement Company
12:00am
425
EX-99.1
hpmvj 0ghl7ch
6 Mar 15
Business combination disclosure
12:00am
8-K
EX-99.1
ythct r2y6
6 Mar 15
Regulation FD Disclosure
12:00am
8-K
EX-10.1
am7541brwl6wq1a
26 Nov 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
criaf8bcq h7s
1 Nov 11
Targacept Reports Third Quarter 2011 Financial Results
12:00am